US Researchers Patent Low-Cost Printer To Track Health Of HIV Patients

The portable device assist clinicians to count the number of CD4 cells and help doctors and patients in low-resource settings who do not have access to flow cytometers.

A low-cost printer that helps HIV patients living in low-resource settings, track the health of their cells has been patented by the US researchers.

HIV positive patients should participate in regular check-ups to keep track of their health. Patients living in high resource settings, devices such as flow cytometers complete the tests by analyzing the blood. However, the cost of such machines are USD 50,000, and regions with limited resources can hardly afford them.

Rectal Microbicide Formulated as an Enema May Prevent HIV
In view of the expanding global HIV epidemics, there is an immediate need for novel HIV prevention options, such as the douche-based rectal microbicides.

As a solution to this, Thomas Boland, a Professor of metallurgical, materials and biomedical engineering at University of Texas has created a less expensive, battery-powered health monitoring tool for use in third world countries.

The device is portable. It assists clinicians count the number of CD4 cells - cells that are attacked by HIV- in the body. The blood drawn is mixed with magnetic microscale beads that latch on to CD4 cells in the blood.

The mixture is placed in an inkjet printer that is modified to print out cells instead of ink. The cells are shot out horizontally onto a magnetized microscopic slide.

Initial HIV Care at Home may Increase Use of ART
Offering optional home care initiation after HIV self testing could be linked to a significant increase in the number of adults initiating antiretroviral therapy compared to standard HIV care

CD4 cells in the blood will be attached to the slide and the cells that do not need to be counted will dribble down into an excess container. Doctors can then look at the slide through a microscope to count the number of CD4 cells on it. The total number of CD4 cells in an individual’s body will be calculated using a equation. The procedure takes less than 20 minutes.

Source-Medindia

$6 Million Grant Awarded By Bill Gates To Develop a Alternative HIV/AIDS Vaccine
Scientists at The Scripps Research Institute (TSRI) received the grant to make the already shown effective HIV/AIDS vaccine in animals for humans.

Detail of HIV's Inner Coat may Lead to New Therapies
For the first time, researchers have described that the 4-million-atom structure of the HIV's capsid, or protein shell.